Study of children with congenital nevi over time
Part of Cancer, Mental health clinical trials.
This study follows babies and toddlers with medium to large birthmarks to understand how they change over time and plan the best care. It will help doctors give better advice to families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 2 years old at the start of the study.
- Your child has a medium, large, or giant brown birthmark (congenital nevus) that is either a single spot or multiple spots.
- Your family has health insurance (Social Security) in France.
- You agree to let your child take part and sign a consent form.
- You can bring your child to yearly checkups for the study.
- You or your child's other parent speaks French well enough to communicate with the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how children with complex congenital heart defects develop, especially their brain and learning skills. It will help doctors provide better support for these children.
This study looks at how certain birthmarks (nevi) change over time and might turn into melanoma. By studying tissue samples, researchers hope to better understand this process.
This study explores how parents feel and cope when their child has a large congenital melanocytic nevus, a type of birthmark. You would take part in a one-on-one interview to share your experience.
This study looks at how removing a large birthmark mole (a congenital melanocytic nevus) affects children’s quality of life and how much they feel stigmatized. It may help doctors understand what to expect and how to support kids before and after surgery.
This Phase 1 study looks at genetic risk factors in children with unusual skin lesions. The goal is to help doctors better decide which spots should be closely watched or safely biopsied.
This study talks with people who have NF1 (and caregivers of children with NF1) about how visible tumors affect them. The goal is to create questionnaires that measure these concerns, which could lead to better support and treatments.
Hear when a new Naevi trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.